Synergistic anti-cancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells

Food and Chemical Toxicology

Volumn 52, Issue , 2013, Pages 61-68

  Lee, Yoon Jin ^a   Lee, Yong Jin ^a   Im, Jae Hyuk ^a   Won, Seong Youn ^a   Kim, Yong Bae ^a   Cho, Moon Kyun ^a   Nam, Hae Seon ^a   Choi, Young Jin ^a   Lee, Sang Han ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

Akt; C Met; Clofarabine; Mesothelioma; Resveratrol; Specificity protein 1

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CLOFARABINE; CYCLIN D1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P21; RESVERATROL; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR SP1;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE PRODUCT; GENE TARGETING; HUMAN; HUMAN CELL; IC 50; MALIGNANT MESOTHELIOMA; PHYTOCHEMISTRY; PROTEIN CONTENT; PROTEIN EXPRESSION; UPREGULATION;

ADENINE NUCLEOTIDES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARABINONUCLEOSIDES; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMONES; CYCLIN D1; ENZYME INHIBITORS; EPITHELIAL CELLS; HUMANS; MESOTHELIOMA; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MET; SP1 TRANSCRIPTION FACTOR; STILBENES;

EID: 84869868260     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.10.060     Document Type: Article

References (37)

1. Altomare D.A., You H., Xiao G.H., Ramos-Nino M.E., Skele K.L., De Rienzo A., Jhanwar S.C., Mossman B.T., Kane A.B., Testa J.R. Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth. Oncogene 2005, 24:6080-6089.
2. Besson A., Yong V.W. Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression. Mol. Cell Biol. 2000, 20:4580-4590.
3. Bhardwaj A., Sethi G., Vadhan-Raj S., Bueso-Ramos C., Takada Y., Gaur U., Nair A.S., Shishodia S., Aggarwal B.B. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappa B-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 2007, 109:2293-2302.
4. Biggs J.R., Kudlow J.E., Kraft A.S. The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J. Biol. Chem. 1996, 271:901-906.
5. Bottaro D.P., Rubin J.S., Faletto D.L., Chan A.M., Kmiecik T.E., Vande Woude G.F., Aaronson S.A. Identification of the hepatocyte growth factor receptor as the c-Met proto-oncogene product. Science 1991, 251:802-804.
6. Bouwman P., Philipsen S. Regulation of the activity of Sp1-related transcription factors. Mol. Cell Endocrinol. 2002, 195:27-38.
7. Cacciotti P., Barbone D., Porta C., Altomare D.A., Testa J.R., Mutti L., Gaudino G. SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure. Cancer Res. 2005, 65:5256-5262.
8. Christensen J.G., Burrows J., Salgia R. C-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention. Cancer Lett. 2005, 225:1-26.
9. Fuhrer G., Lazarus A.A. Mesothelioma. Dis. Mon. 2011, 57:40-54.
10. Gatouillat G., Balasse E., Joseph-Pietras D., Morjani H., Madoulet C. Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma. J. Cell. Biochem. 2010, 110:893-902.
11. Genini D., Adachi S., Chao Q., Rose D.W., Carrera C.J., Cottam H.B., Carson D.A., Leoni L.M. Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria. Blood 2000, 96:3537-3543.
12. Gidoni D., Dynan W.S., Tjian R. Multiple specific contacts between a mammalian transcription factor and its cognate promoters. Nature 1984, 312:409-413.
13. Guan H., Cai J., Zhang N., Wu J., Yuan J., Li J., Li M. Sp1 is upregulated in human glioma, promotes MMP-2-mediated cell invasion and predicts poor clinical outcome. Int. J. Cancer 2012, 130:593-601.
14. Kannaiyan R., Hay H.S., Rajendran P., Li F., Shanmugam M.K., Vali S., Abbasi T., Kapoor S., Sharma A., Kumar A.P., Chng W.J., Sethi G. Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells. Br. J. Pharmacol. 2011, 164:1506-1521.
15. Kavurma M.M., Khachigian L.M. Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4-p21WAF1/Cip1 complex formation. J. Biol. Chem. 2003, 278:32537-32543.
16. Lee Y.J., Jeong H.Y., Kim Y.B., Lee Y.J., Won S.Y., Shim J.H., Cho M.K., Nam H.S., Lee S.H. Reactive oxygen species and PI3K/Akt signaling play key roles in the induction of Nrf2-driven heme oxygenase-1 expression in sulforaphane-treated human mesothelioma MSTO-211H cells. Food Chem. Toxicol. 2012, 50:116-123.
17. Lou Z., O'Reilly S., Liang H., Maher V.M., Sleight S.D., McCormick J.J. Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation. Cancer Res. 2005, 65:1007-1017.
18. Maulik G., Shrikhande A., Kijima T., Ma P.C., Morrison P.T., Salgia R. Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev. 2002, 13:41-59.
19. Michalides R., van Veelen N., Hart A., Loftus B., Wientjens E., Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res. 1995, 55:975-978.
20. Mikami I., Zhang F., Hirata T., Okamoto J., Koizumi K., Shimizu K., Jablons D., He B. Inhibition of activated phosphatidylinositol 3-kinase/AKT pathway in malignant pleural mesothelioma leads to G1 cell cycle arrest. Oncol. Rep. 2010, 24:1677-1681.
21. Mitsuuchi Y., Johnson S.W., Selvakumaran M., Williams S.J., Hamilton T.C., Testa J.R. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel. Cancer Res. 2000, 60:5390-5394.
22. Nabekura T., Kamiyama S., Kitagawa S. Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochem. Biophys. Res. Commun. 2005, 327:866-870.
23. Nakashima K., Virgona N., Miyazawa M., Watanabe T., Yano T. The tocotrienol-rich fraction from rice bran enhances cisplatin-induced cytotoxicity in human mesothelioma H28 cells. Phytother. Res. 2010, 24:1317-1321.
24. Papineni S., Chintharlapalli S., Abdelrahim M., Lee S.O., Burghardt R., Abudayyeh A., Baker C., Herrera L., Safe S. Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met. Carcinogenesis 2009, 30:1193-1201.
25. Quan F., Pan C., Ma Q., Zhang S., Yan L. Reversal effect of resveratrol on multidrug resistance in KBv200 cell line. Biomed. Pharmacother. 2008, 62:622-629.
26. Sankpal U.T., Goodison S., Abdelrahim M., Basha R. Targeting Sp1 transcription factors in prostate cancer therapy. Med. Chem. 2011, 7:518-525.
27. Shi Q., Le X., Abbruzzese J.L., Peng Z., Qian C.N., Tang H., Xiong Q., Wang B., Li X.C., Xie K. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res. 2001, 61:4143-4154.
28. Singh V., Singh S.M. Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs. Anticancer Drugs 2007, 18:1123-1132.
29. Spirtas R., Heineman E.F., Bernstein L., Beebe G.W., Keehn R.J., Stark A., Harlow B.L., Benichou J. Malignant mesothelioma: attributable risk of asbestos exposure. Occup. Environ. Med. 1994, 51:804-811.
30. Tvrdík D., Dundr P., Povýsil C., Pytlík R., Planková M. Up-regulation of p21WAF1 expression is mediated by Sp1/Sp3 transcription factors in TGFbeta1-arrested malignant B cells. Med. Sci. Monit. 2006, 12:227-234.
31. Wilson S.M., Barbone D., Yang T.M., Jablons D.M., Bueno R., Sugarbaker D.J., Nishimura S.L., Gordon G.J., Broaddus V.C. MTOR mediates survival signals in malignant mesothelioma grown as tumor fragment spheroids. Am. J. Respir. Cell Mol. Biol. 2008, 39:576-583.
32. Xie K.C., Plunkett W. Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine. Cancer Res. 1996, 56:3030-3037.
33. Xie W., He Y., Huo D., Huang Y., Wu W. A mimic of phosphorylated prolactin inhibits human breast cancer cell proliferation via upregulation of p21 waf1. Med. Oncol. 2010, 27:1340-1345.
34. Yao J.C., Wang L., Wei D., Gong W., Hassan M., Wu T.T., Mansfield P., Ajani J., Xie K. Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin. Cancer Res. 2004, 10:4109-4117.
35. Yu C., Rahmani M., Conrad D., Subler M., Dent P., Grant S. The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571. Blood 2003, 102:3765-3774.
36. Yuan P., Wang L., Wei D., Zhang J., Jia Z., Li Q., Le X., Wang H., Yao J., Xie K. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer. Cancer 2007, 110:2682-2690.
37. Zhao W., Bao P., Qi H., You H. Resveratrol down-regulates survivin and induces apoptosis in human multidrug-resistant SPC-A-1/CDDP cells. Oncol. Rep. 2010, 23:279-286.